Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
The Journal of Pathology
|
November 6, 2023
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm, et al.
The Journal of Clinical Investigation
|
November 27, 2019
The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors
Bianca Balbino, Pauline Herviou, Ophélie Godon, et al.
Nature Communications
|
May 12, 2021
Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice
Eva Conde, Romain Bertrand, Bianca Balbino, et al.
Nature Immunology
|
June 13, 2017
IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions
Chang-Han Lee, Gabrielle Romain, Wupeng Yan, et al.
Mabs
|
July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies
Frank R Brennan, J Ryan Polli, Jean Sathish, et al.
Science Immunology
|
January 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling
Karel F A Van Damme, Dorine Sichien, Katrien Van der Borght, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
The Journal of Pathology
|
November 6, 2023
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm, et al.
The Journal of Clinical Investigation
|
November 27, 2019
The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors
Bianca Balbino, Pauline Herviou, Ophélie Godon, et al.
Nature Communications
|
May 12, 2021
Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice
Eva Conde, Romain Bertrand, Bianca Balbino, et al.
Nature Immunology
|
June 13, 2017
IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions
Chang-Han Lee, Gabrielle Romain, Wupeng Yan, et al.
Mabs
|
July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies
Frank R Brennan, J Ryan Polli, Jean Sathish, et al.
Science Immunology
|
January 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling
Karel F A Van Damme, Dorine Sichien, Katrien Van der Borght, et al.
Page
of 2